ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Claris Biotherapeutics raised $118 million in Series B funding. The biotech company secured the financing round to advance its pipeline of therapies. The funding will support continued development of its clinical programs.
Tap to vote and see what everyone thinks.
Summary by ByteBrief